NO20055774L - Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere - Google Patents

Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere

Info

Publication number: NO20055774L
Authority: NO; Norway
Prior art keywords: protein formulations; pharmaceutical containers; coated pharmaceutical; stabilized protein; liquid stabilized
Prior art date: 2003-05-13

Application number

NO20055774A

Other languages

English (en)

Norwegian (no)

Other versions

NO20055774D0 (no

Inventor

Fabrizio Samaritani

Alessandra Del Rio

Original Assignee

Ares Trading Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-13

Filing date

2005-12-06

Publication date

2005-12-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055774(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-06 Application filed by Ares Trading Sa filed Critical Ares Trading Sa

2005-12-06 Publication of NO20055774D0 publication Critical patent/NO20055774D0/no

2005-12-06 Publication of NO20055774L publication Critical patent/NO20055774L/no

Links

239000000203 mixture Substances 0.000 title abstract 3
238000009472 formulation Methods 0.000 title abstract 2
239000007788 liquid Substances 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
102000003996 Interferon-beta Human genes 0.000 abstract 2
108090000467 Interferon-beta Proteins 0.000 abstract 2
229960001388 interferon-beta Drugs 0.000 abstract 2
CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 abstract 1
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
229930195722 L-methionine Natural products 0.000 abstract 1
239000004809 Teflon Substances 0.000 abstract 1
229920006362 Teflon® Polymers 0.000 abstract 1
239000007853 buffer solution Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000012669 liquid formulation Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
229960004452 methionine Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229920001993 poloxamer 188 Polymers 0.000 abstract 1
229940044519 poloxamer 188 Drugs 0.000 abstract 1
BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/005—Closures provided with linings or internal coatings so as to avoid contact of the closure with the contents
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Mechanical Engineering (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

NO20055774A 2003-05-13 2005-12-06 Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere NO20055774L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03010671		2003-05-13
PCT/EP2004/050779 WO2004100979A2 (fr)	2003-05-13	2004-05-12	Formulations de proteines liquides stabilisees dans des emballages pharmaceutiques

Publications (2)

Publication Number	Publication Date
NO20055774D0 NO20055774D0 (no)	2005-12-06
NO20055774L true NO20055774L (no)	2005-12-06

Family

ID=33442722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055774A NO20055774L (no)	2003-05-13	2005-12-06	Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere

Country Status (22)

Country	Link
US (2)	USRE43331E1 (fr)
EP (2)	EP1633388B1 (fr)
JP (2)	JP2007502684A (fr)
KR (1)	KR101084412B1 (fr)
CN (1)	CN1809376B (fr)
AR (1)	AR044302A1 (fr)
AU (1)	AU2004237982C1 (fr)
BR (1)	BRPI0410679A (fr)
CA (1)	CA2523477A1 (fr)
CY (1)	CY1115233T1 (fr)
DK (1)	DK1633388T3 (fr)
EA (1)	EA008308B1 (fr)
ES (1)	ES2471942T3 (fr)
HR (1)	HRP20140267T1 (fr)
IL (1)	IL171912A (fr)
MX (1)	MXPA05012191A (fr)
NO (1)	NO20055774L (fr)
PL (1)	PL1633388T3 (fr)
PT (1)	PT1633388E (fr)
SI (1)	SI1633388T1 (fr)
UA (1)	UA91493C2 (fr)
WO (1)	WO2004100979A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA200609412B (en) *	2004-05-17	2008-07-30	Ares Trading Sa	Hydrogel interferon formulations
JP4988562B2 (ja) *	2004-06-01	2012-08-01	アレストレーディングソシエテアノニム	安定化したインターフェロン液体製剤
AU2006204937B2 (en) *	2005-01-12	2011-02-10	Biogen Ma Inc.	Method for delivering Interferon-beta
WO2007016562A2 (fr) *	2005-07-29	2007-02-08	Amgen Inc.	Formulations inhibant l'agregation de proteines
WO2007127668A2 (fr) *	2006-04-26	2007-11-08	Wyeth	Nouveaux procedes de revetement d'un contenant empechant la precipitation de formulations de conjugues de polysaccharide-proteine
KR100785070B1 (ko)	2006-07-11	2007-12-12	삼성전자주식회사	휴대 단말기에서 디지털 저작권 관리 콘텐츠 재생 방법 및장치
EP2170268A2 (fr)	2007-06-25	2010-04-07	Amgen, Inc.	Compositions d'agents de liaison spécifiques vis-à-vis du facteur de croissance des hépatocytes
JP5563475B2 (ja) *	2007-12-20	2014-07-30	メルクセローノソシエテアノニム	Ｐｅｇインターフェロン−ベータ製剤
JP5933975B2 (ja)	2008-11-12	2016-06-15	メディミューン，エルエルシー	抗体製剤
BR112012013093A2 (pt)	2009-12-21	2017-12-12	Genentech Inc	''formulação farmacêutica aquosa estável, artigo, métodos para estabilizar um anticorpo, para tratamento de uma doença ou distúrbio em um indivíduo, para reduzir a agregação de um anticorpo monoclonal terapêutico e de fabricação de uma formulação farmaceutica, frasco e tanque de aço inoxidável
US8802603B2 (en)	2010-06-17	2014-08-12	Becton, Dickinson And Company	Medical components having coated surfaces exhibiting low friction and low reactivity
WO2012022734A2 (fr)	2010-08-16	2012-02-23	Medimmune Limited	Anticorps anti-icam-1 et procédés d'utilisation
FR2966044B1 (fr) *	2010-10-18	2012-11-02	Sanofi Pasteur	Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
WO2013158273A1 (fr)	2012-04-20	2013-10-24	Abbvie Inc.	Procédés de modulation de la distribution de variant de lysine c-terminal
WO2013176754A1 (fr)	2012-05-24	2013-11-28	Abbvie Inc.	Nouvelle purification d'anticorps au moyen de chromatographie à interaction hydrophobe
EP4414376A3 (fr)	2012-12-03	2024-11-06	Novobiotic Pharmaceuticals, LLC	Nouveau depsipeptide et ses utilisations
BR112015017307A2 (pt)	2013-03-14	2017-11-21	Abbvie Inc	composições de espécies com baixa acidez e métodos para produção e uso das mesmas
CA2899449A1 (fr)	2013-03-14	2014-10-02	Abbvie Inc.	Composition d'especes faiblement acides et leurs methodes de production utilisant la chromatographie de deplacement
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
WO2015050959A1 (fr)	2013-10-01	2015-04-09	Yale University	Anticorps anti-kits et leurs méthodes d'utilisation
BR112016010475B1 (pt) *	2014-03-13	2021-07-20	Stevanato Group International A.S.	Método de manuseio de uma formulação farmacêutica líquida
WO2016004197A1 (fr)	2014-07-03	2016-01-07	Abbvie Inc.	Méthodes de modulation de profils de glycosylation de protéines de produits thérapeutiques protéiques de recombinaison à l'aide de cobalt
WO2016007764A1 (fr)	2014-07-09	2016-01-14	Abbvie Inc.	Procédés pour moduler le profil de glycosylation de protéines recombinantes au moyen de sucres non utilisés couramment
WO2016144773A1 (fr)	2015-03-06	2016-09-15	Abbvie Inc.	Glycoprotéines arabinosylées
WO2016163764A2 (fr) *	2015-04-07	2016-10-13	에이비온 주식회사	Préparation stabilisée de variant d'interféron-bêta
ES2871199T3 (es)	2015-09-24	2021-10-28	Matrix Biology Inst	Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
WO2017147003A1 (fr)	2016-02-26	2017-08-31	Novobiotic Pharmaceuticals, Llc	Nouveaux antibiotiques macrocycliques et leurs utilisations
FI126979B (en)	2016-02-29	2017-09-15	Faron Pharmaceuticals Oy	Lyophilized pharmaceutical formulation and its use
CN110612306B (zh)	2017-04-04	2024-05-07	诺沃生物医药有限责任公司	新缩肽类及其用途
US12161777B2 (en)	2020-07-02	2024-12-10	Davol Inc.	Flowable hemostatic suspension
US11739166B2 (en)	2020-07-02	2023-08-29	Davol Inc.	Reactive polysaccharide-based hemostatic agent
JP2024500994A (ja)	2020-12-28	2024-01-10	デボル，インコーポレイテッド	タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2622598A (en) *	1951-03-08	1952-12-23	Premo Pharmaceutical Lab Inc	Drain-clear container for aqueous liquid pharmaceutical preparations
US5183746A (en) *	1986-10-27	1993-02-02	Schering Aktiengesellschaft	Formulation processes for pharmaceutical compositions of recombinant β-
DE69329193T2 (de) *	1992-05-06	2001-01-18	Mallinckrodt, Inc.	Behälter und verschluss zur aufrechterhaltung der stabilität von natriumhypochloritlösungen
US5661125A (en)	1992-08-06	1997-08-26	Amgen, Inc.	Stable and preserved erythropoietin compositions
TW249202B (fr) *	1993-08-13	1995-06-11	Ciba Gerigy Corp
JP2758154B2 (ja) *	1995-04-06	1998-05-28	エフ・ホフマン−ラロシユアーゲー	インターフェロンを含む液体製剤
WO1997017087A1 (fr)	1995-11-07	1997-05-15	Genentech, Inc.	Formulation stabilisante pour le facteur humain de croissance nerveuse
US6142977A (en)	1996-10-18	2000-11-07	Schering Ag	Prefilled, sterilized syringe with a new and improved plug
TR199901968T2 (xx)	1996-12-24	1999-12-21	Biogen, Inc.	Sabit s�v� interferon form�lleri.
US6171586B1 (en) *	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
CN2326243Y (zh) *	1997-09-29	1999-06-30	程继勇	覆膜药用瓶塞
US6667299B1 (en)	2000-03-16	2003-12-23	Hollis-Eden Pharmaceuticals, Inc.	Pharmaceutical compositions and treatment methods
CN2441750Y (zh) *	2000-06-23	2001-08-08	程继勇	表面覆膜药用橡胶瓶塞
JP2002209975A (ja) *	2001-01-19	2002-07-30	Daikyo Seiko Ltd	医薬バイアル用ラミネートゴム栓
CN1133565C (zh) *	2001-10-18	2004-01-07	郑秀娣	药品瓶塞隔离膜

2004
- 2004-05-11 AR ARP040101607 patent/AR044302A1/es not_active Application Discontinuation
- 2004-05-12 WO PCT/EP2004/050779 patent/WO2004100979A2/fr not_active Ceased
- 2004-05-12 UA UAA200510442A patent/UA91493C2/uk unknown
- 2004-05-12 US US13/151,459 patent/USRE43331E1/en not_active Expired - Lifetime
- 2004-05-12 JP JP2006530185A patent/JP2007502684A/ja not_active Withdrawn
- 2004-05-12 ES ES04760770.0T patent/ES2471942T3/es not_active Expired - Lifetime
- 2004-05-12 CN CN2004800169917A patent/CN1809376B/zh not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410679 patent/BRPI0410679A/pt not_active IP Right Cessation
- 2004-05-12 AU AU2004237982A patent/AU2004237982C1/en not_active Expired
- 2004-05-12 KR KR20057021160A patent/KR101084412B1/ko not_active Expired - Fee Related
- 2004-05-12 HR HRP20140267TT patent/HRP20140267T1/hr unknown
- 2004-05-12 CA CA 2523477 patent/CA2523477A1/fr not_active Withdrawn
- 2004-05-12 MX MXPA05012191A patent/MXPA05012191A/es active IP Right Grant
- 2004-05-12 SI SI200432149T patent/SI1633388T1/sl unknown
- 2004-05-12 EP EP04760770.0A patent/EP1633388B1/fr not_active Expired - Lifetime
- 2004-05-12 DK DK04760770T patent/DK1633388T3/da active
- 2004-05-12 PL PL04760770T patent/PL1633388T3/pl unknown
- 2004-05-12 US US10/556,467 patent/US7540382B2/en not_active Ceased
- 2004-05-12 EA EA200501692A patent/EA008308B1/ru not_active IP Right Cessation
- 2004-05-12 EP EP20110152658 patent/EP2324845A1/fr not_active Withdrawn
- 2004-05-12 PT PT04760770T patent/PT1633388E/pt unknown
2005
- 2005-11-13 IL IL17191205A patent/IL171912A/en active IP Right Grant
- 2005-12-06 NO NO20055774A patent/NO20055774L/no not_active Application Discontinuation
2012
- 2012-01-13 JP JP2012005485A patent/JP2012096063A/ja active Pending
2014
- 2014-05-30 CY CY20141100386T patent/CY1115233T1/el unknown

Also Published As

Publication number	Publication date
EP1633388B1 (fr)	2014-03-19
AU2004237982C1 (en)	2018-03-08
PL1633388T3 (pl)	2014-08-29
IL171912A (en)	2015-02-26
BRPI0410679A (pt)	2006-06-20
NO20055774D0 (no)	2005-12-06
EP2324845A1 (fr)	2011-05-25
AU2004237982A1 (en)	2004-11-25
JP2012096063A (ja)	2012-05-24
MXPA05012191A (es)	2006-02-08
USRE43331E1 (en)	2012-05-01
JP2007502684A (ja)	2007-02-15
US7540382B2 (en)	2009-06-02
PT1633388E (pt)	2014-06-25
AU2004237982B2 (en)	2010-03-04
WO2004100979A3 (fr)	2005-05-19
HK1088558A1 (zh)	2006-11-10
CN1809376B (zh)	2010-04-28
ES2471942T3 (es)	2014-06-27
WO2004100979A2 (fr)	2004-11-25
EA008308B1 (ru)	2007-04-27
IL171912A0 (en)	2006-04-10
CY1115233T1 (el)	2017-01-04
KR20060009913A (ko)	2006-02-01
HRP20140267T1 (hr)	2014-04-25
EA200501692A1 (ru)	2006-06-30
AR044302A1 (es)	2005-09-07
EP1633388A2 (fr)	2006-03-15
SI1633388T1 (sl)	2014-05-30
KR101084412B1 (ko)	2011-11-21
CN1809376A (zh)	2006-07-26
CA2523477A1 (fr)	2004-11-25
US20070092487A1 (en)	2007-04-26
DK1633388T3 (da)	2014-04-07
UA91493C2 (uk)	2010-08-10

Legal Events

Date	Code	Title	Description
2017-09-11	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20055774L (no)	2005-12-06	Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere
ES2569949T3 (es)	2016-05-13	Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
AR092919A2 (es)	2015-05-06	Composicion farmaceutica liquida
IL172835A0 (en)	2006-06-11	A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
BRPI0410488A (pt)	2006-06-13	composição farmacêutica lìquida estabilizada livre de hsa, método para preparação de composição farmacêutica lìquida estabilizada livre de hsa, recipiente vedado hermeticamente e kit para administração de múltiplas doses de composição farmacêutica lìquida estabilizada livre de hsa'
NO953278D0 (no)	1995-08-21	Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
JP2007502684A5 (fr)	2012-03-08
NZ505324A (en)	2002-11-26	Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
CO5660273A2 (es)	2006-07-31	Formulaciones de proteina y anticuerpo de alta concentracion
DK1589945T3 (da)	2011-09-05	Topisk farmaceutisk og/eller kosmetisk dispenseringssystem
GEP20012549B (en)	2001-10-25	Pharmaceutical Composition Containing Sumatriptan
DE60126433D1 (de)	2007-03-22	Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
MXPA04000627A (es)	2004-04-20	COMPOSICIONES FARMACeUTICAS Y USO DE LAS MISMAS.
JP5202986B2 (ja)	2013-06-05	コンタクトレンズ装着液
ATE252376T1 (de)	2003-11-15	Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln
NO20065860L (no)	2006-12-19	Stabiliserte flytende interferonformuleringer
ZA200409616B (en)	2006-05-31	Pharmaceutical preperations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
BRPI0412364A (pt)	2006-09-05	composição farmacêutica sólida, compreendendo amisulpride
SI1691825T1 (sl)	2011-12-30	Stabilizirane tekoäśe farmacevtske oblike interferona
AR034749A1 (es)	2004-03-17	Formulaciones de interferon beta humano
AR037131A1 (es)	2004-10-20	Formulaciones de jarabe de ribavirina
NO20010537D0 (no)	2001-01-31	Farmasöytiske preparater omfattende ibuprofen og domperidon
GEP20043313B (en)	2004-03-10	Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility
BR9815966A (pt)	2001-02-28	Formulação humano de interferon beta-1a (ifn-beta-1a) recombinante
BR0111018A (pt)	2004-02-17	Formulações estáveis lìquidas e sólidas